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The tyrosine phosphatase CD148 is excluded from 
the immunologic synapse and down-regulates 
prolonged T cell signaling
 
Joseph Lin and Arthur Weiss
 
Department of Medicine and Department of Microbiology and Immunology, Biomedical Sciences Graduate Program, 
 
Howard Hughes Medical Institute, Rosalind Russell Medical Research Center for Arthritis, University of California at San Francisco, 
San Francisco, CA 94143
 
D148 is a receptor-like protein tyrosine phos-
phatase up-regulated on T cells after T cell receptor
(TCR) stimulation. To examine the physiologic role
of CD148 in TCR signaling, we used an inducible CD148-
expressing Jurkat T cell clone. Expression of CD148 inhibits
NFAT (nuclear factor of activated T cells) activation induced
by soluble anti-TCR antibody, but not by antigen-presenting
cells (APCs) loaded with staphylococcal enterotoxin super-
antigen (SAg) or immobilized anti-TCR antibody. Immuno-
fluorescence microscopy revealed that the extracellular
C
 
domain of CD148 mediates its exclusion from the immu-
nologic synapse, sequestering it from potential substrates.
Targeting of the CD148 phosphatase domain to the immu-
nologic synapse potently inhibited NFAT activation by all
means of triggering through the TCR. These data lead us to
propose a model where CD148 function is regulated in
part by exclusion from substrates in the immunologic syn-
apse. Upon T cell–APC disengagement, CD148 can then
access and dephosphorylate substrates to down-regulate
prolongation of signaling.
 
Introduction
 
The activation of a T cell requires the complex interactions of
a vast number of signaling molecules and eventually results in
proliferation, differentiation, and secretion of cytokines such
as interleukin 2 (IL-2). The initial triggering events are regu-
lated by the Src and Syk families of protein tyrosine kinases
(Kane et al., 2000; Lin and Weiss, 2001b). These kinases
phosphorylate a large number of substrates leading to the
further activation of other enzymes and allow for molecules
with no intrinsic enzymatic activity to function as adaptors
for the assembly of signaling complexes (Tomlinson et al.,
2000). One such adaptor is the linker for the activation of T
cells (LAT) (Zhang et al., 1998). LAT is a transmembrane
adaptor protein containing multiple sites of tyrosine phos-
phorylation, which allow for the recruitment of many essential
 
signaling molecules, including phospholipase C
 

 
-1 (PLC
 

 
-1),
Grb2, and Gads (Finco et al., 1998; Zhang et al., 1999, 2000;
Tomlinson et al., 2000; Lin and Weiss, 2001a). Multiple
groups have demonstrated that signals emanating from the T
cell receptor (TCR) must be sustained for prolonged periods
of time, on the order of hours, for T cells to proliferate (Iezzi
et al., 1998; Lee et al., 2002). IL-2 production also requires a
similar length of time; for instance, 6 h of stimulation with
Con A and PMA were required for commitment to maximal
IL-2 production in Jurkat T cells (Weiss et al., 1987).
In order for a productive T cell–antigen-presenting cell
(APC) conjugate to form, a number of cell surface molecules
must bind their respective ligands. During this cell–cell inter-
action, many proteins localize to the area of cell–cell contact,
whereas others are excluded. Studies originally performed in
mouse T cell clones demonstrated that the contact point
between the T cell and the APC is a highly ordered structure
(Monks et al., 1998). This structure has become known as
the immunologic synapse (Bromley et al., 2001). To mimic
what was seen in mouse T cell clones, we used the Jurkat–
superantigen (SAg) system, where Jurkat T cells are stimulated
with staphylococcal enterotoxin SAg presented on B lympho-
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blastoid cells. SAgs function by simultaneously binding to
the 
 

 
 chain of the TCR and major histocompatibility com-
plex (MHC) class II molecules on the APC. This interaction
has a similar activation time course as that seen with peptide
loaded onto MHC molecules (Lavoie et al., 1999). Molecules
known to be excluded from the synapse in mouse clones,
such as CD43 and CD45, are also excluded in the Jurkat–
SAg system (Johnson et al., 2000; van der Merwe et al.,
2000; Delon et al., 2001; Bunnell et al., 2002).
Many groups have studied the signals involved in activating
T cells, but considerably less is known about how a T cell ter-
minates its response to stimulation. A class of molecules
thought to play a role in the down-regulation process is ty-
rosine phosphatases. CD148, also known as Dep-1 and Byp, is
a transmembrane tyrosine phosphatase that is up-regulated on
T cells after activation (Tangye et al., 1998a). The extracellular
domain consists of eight fibronectin type III domains, with
multiple glycosylation sites that add to the size of the molecule
(Gaya et al., 1999). Because of its bulky extracellular domain,
it is likely to be excluded from the immunologic synapse, simi-
lar to other proteins with bulky extracellular domains, such as
CD43 and CD45 (Johnson et al., 2000; van der Merwe et al.,
2000; Delon et al., 2001). Previous work has shown that
CD148 is a negative regulator of TCR signaling, as the activity
of the TCR-induced transcription factor NFAT (nuclear factor
of activated T cells) was reduced in CD148-expressing cells
(Tangye et al., 1998b; Baker et al., 2001). CD148 can act as a
negative regulator by causing the specific dephosphorylation of
LAT and PLC-
 

 
1 (Baker et al., 2001). However, in these stud-
ies, cells were only stimulated with soluble anti-TCR antibod-
ies that do not mimic the physiologic interaction that leads to
the formation of an immunologic synapse.
To further study the role of CD148 in T cell signaling, we
investigated whether expression of CD148 inhibits T cell ac-
tivation induced not only by soluble anti-TCR antibody (Ab)
stimulation, but also with either SAg and APCs or immobi-
lized anti-TCR Ab. We found that at 8 h after stimulation,
CD148 only inhibits T cell activation stimulated with soluble
anti-TCR. Immunofluorescence revealed that CD148 is ex-
cluded from the immunologic synapse and would therefore
be unable to interact with substrates localized to the synapse,
such as LAT (Tanimura et al., 2003). This exclusion is medi-
ated, at least in part, by the large extracellular domain of
CD148. Forced targeting of the CD148 phosphatase domain
to the synapse results in the potent inhibition of NFAT acti-
vation independent of the technique used to trigger the TCR.
These data lead us to propose a model whereby CD148 activ-
ity during early T cell–APC interactions is regulated by exclu-
sion from the immunologic synapse. After T cell–APC disen-
gagement, CD148 is no longer excluded by the synapse and
can then access and dephosphorylate substrates to down-regu-
late prolongation of the response. Exclusion from the synapse
could provide an important level of regulation, to prevent the
premature termination of signaling pathways.
 
Results
 
Differential effects of CD148 depending on stimuli
 
To examine the negative regulatory role of CD148 on TCR
signaling using more physiologic stimuli, we used APCs
loaded with staphylococcal enterotoxin (SE) SAg. The SAg-
coated APCs provide a localized stimulus to which a T cell
will polarize to after appropriate TCR stimulation. These
changes can be visualized as directed actin polymerization
and microtubule organizing center reorientation (Lowin-
Kropf et al., 1998). Jurkat T cells were transfected with
wild-type murine CD148 together with an NFAT–lucif-
erase reporter construct. Cells were stimulated the next day
with either soluble anti-TCR (C305 mAb) or two types of
SAg (SED or SEE) with Daudi B lymphoblastoid cells serv-
ing as APCs. As previously reported, expression of CD148
in Jurkat T cells inhibited soluble anti-TCR–induced NFAT
activation by 
 

 
60–70% (Baker et al., 2001). Interestingly,
stimulation with either SAgs was not associated with sub-
stantial decreases in the NFAT response when CD148 was
expressed (Fig. 1 A). A potential concern when comparing
soluble anti-TCR with SAg and APCs is that APCs present a
number of additional ligands to the T cell besides the SAg
bound to MHC class II molecule during the interaction. To
rule out the possibility that these other interactions ac-
counted for the differences seen, we coated plates with the
same anti-TCR used for the soluble mAb stimulation. Stim-
ulation with immobilized anti-TCR mimics the polarized
stimulus provided by the SAg and APC. As seen with the
SAg and APC stimulation, NFAT activation in response to
various concentrations of plate-bound anti-TCR stimulation
was not substantially inhibited by the expression of CD148
(Fig. 1 B). The average percent inhibition induced by the
various TCR stimuli is shown in Fig. 1 C. Thus, it seems
Figure 1. Expression of CD148 only inhibits NFAT activation 
induced by soluble anti-TCR. Jurkat T cells were transfected with 
2 g of pcdef3-mCD148 or vector control, along with 15 g of a 
3xNFAT–luciferase reporter and rested overnight. (A) Cells were 
then stimulated with soluble anti-TCR (1:2,000 dilution of ascites; 
C305), or with the indicated SAg (250 ng/ml) and APCs. (B) Cells 
transfected as before were stimulated with increasing amounts of 
soluble anti-TCR or plate-bound anti-TCR. For A and B, the mean 
of triplicate samples in one representative experiment is shown. 
(C) The mean percent inhibition for each stimulus is shown from 
multiple experiments. Error bars represent standard errors of the 
mean for at least four separate experiments, each done in triplicate. 
Relative light units were normalized to PMA/ionomycin.
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from these data that CD148 preferentially inhibits a nonpo-
larizing, soluble, anti-TCR stimulation. In contrast, CD148
expression has little effect on polarizing stimuli such as SAg
with APCs or plate-bound anti-TCR.
To further examine the differences in T cell activation
seen with the various methods of triggering through the
TCR, we used a previously characterized CD148-inducible
system in Jurkat T cells (Baker et al., 2001). The early acti-
vation marker CD69 is known to be up-regulated in T cells
stimulated through the TCR. As shown in Fig. 2, expression
of CD148 substantially inhibited the subsequent up-regula-
tion of CD69 induced by an overnight stimulation with sol-
uble anti-TCR. However, in cells stimulated with anti-
TCR–coated beads or SAg and APCs, expression of CD148
did not inhibit the up-regulation of CD69 (Baker et al.,
2001). These data demonstrate that endogenous responses
reflecting T cell activation are also unaffected by CD148 ex-
pression if cells are stimulated by immobilized anti-TCR or
SAg and APCs.
Previous studies have demonstrated that inducible expres-
sion of CD148 leads to a specific loss of LAT and PLC
 

 
-1
phosphorylation induced by soluble anti-TCR stimulation
(Baker et al., 2001). To investigate whether immobilized
anti-TCR stimulation results in the same phosphorylation
pattern, we stimulated Jurkat T cells that express CD148
with either soluble or bead-coated anti-TCR Ab for various
periods of time. Stimulation with soluble anti-TCR in the
presence of CD148 resulted in decreased tyrosine phosphor-
ylation levels of pp140 (PLC
 

 
-1) and pp36 (LAT), com-
pared with cells not expressing CD148, as previously re-
ported (Fig. 3 A) (Baker et al., 2001). Quantitation of
Figure 2. Only soluble anti-TCR–induced CD69 up-regulation is 
inhibited by CD148 expression. Tet-inducible CD148-expressing 
Jurkats (clone L12) were induced with 1 g/ml doxycycline for 48 h 
before stimulation. Cells were then stimulated with soluble anti-
TCR, bead-coated anti-TCR, or SAg (1 g/ml SEE) with Daudi B cells 
serving as APCs, overnight. Cells stimulated with 20 ng/ml PMA  1 
M ionomycin served as positive controls. Cells were then stained 
with anti–CD69-PE and analyzed by flow cytometry. For SAg and 
APC stimulation, T cells were gated with anti–CD5-FITC. The shaded 
histogram represents unstimulated samples or those stimulated with 
APCs only.
Figure 3. CD148 does not affect 
tyrosine phosphorylation induced with 
immobilized anti-TCR. Tet-inducible 
CD148-expressing Jurkats were induced 
as before. Cells were washed once and 
rested in PBS for 30 min before stimulation 
with either (A) soluble anti-TCR or (B) 
bead-coated anti-TCR for the indicated 
time points. Cells were then lysed in 
buffer containing 1% NP-40, and proteins 
were separated by SDS-PAGE. Tyrosine-
phosphorylated proteins were then 
visualized by Western blotting with an 
antiphosphotyrosine mAb followed by 
a goat anti–mouse-HRP secondary. 
(C) Average percent intensity of the 
indicated phosphotyrosine bands from 
three separate experiments is shown 
comparing soluble to bead-coated anti-
TCR stimulation. Blots were developed 
on a Kodak Imaging Station, and bands 
were quantitated using Kodak 1D imaging 
software.
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phosphotyrosine bands from three separate experiments
showed that phosphorylation of pp140 and pp36 was
decreased by 
 

 
50 and 70%, respectively (Fig. 3 C). Inter-
estingly, cells expressing CD148 did not show decreased
phosphorylation of pp140 and pp36 when stimulated with
anti-TCR–coated beads (Fig. 3, B and C). The tyrosine
phosphorylation states of other bands, such as pp70 and
pp56, were similar for either stimulus independent of CD148.
These data show that the initial events in proximal TCR sig-
naling, as assessed by tyrosine phosphorylation, are affected
differently by CD148, depending upon whether soluble or
immobilized anti-TCR is used.
 
CD148 is excluded from the immunologic synapse
 
To study the cellular localization of CD148 during the re-
sponse to the various TCR stimuli, immunofluorescence mi-
croscopy was performed with antibodies specific to CD148
and the CD3
 

 
 chain of the TCR. In resting Jurkat T cells in-
ducibly expressing CD148, both CD148 and CD3 colocalize
at the cell surface (Fig. 4 A). Similarly, after soluble anti-TCR
mAb stimulation, CD148 and CD3 still show almost com-
plete colocalization with very little compartmentalization of
green and red staining (Fig. 4 B). In cells dropped onto cover-
slips coated with anti-TCR Ab, the cells initially make con-
tact and then begin to spread, as previously reported by others
(Bunnell et al., 2002). After 15 min, the cells were visualized
at the cell–coverslip interface with the same antibodies as be-
fore. In striking contrast to a soluble anti-TCR stimulation,
cells stimulated by immobilized anti-TCR showed small clus-
ters of CD3 in the center of the cell–coverslip interface,
whereas CD148 accumulated at the edges of the spread cell
(Fig. 4 C). This pattern of CD148 staining is similar to those
previously described for CD45 and CD43 using Ab-coated
slides (Bunnell et al., 2002). When T cells stimulated with
SAg and APCs were visualized, CD3 clustered tightly at the
interface of the T cell and APC. Staining of CD148 showed
that it was largely excluded from this region of CD3 staining
(Fig. 4 D). To further confirm the exclusion of CD148 from
the immunologic synapse, localization of CD148 was com-
pared with that of CD43 and CD45, two molecules previ-
ously demonstrated to be excluded from the synapse (Johnson
et al., 2000; van der Merwe et al., 2000; Delon et al., 2001).
Figure 4. CD148 does not colocalize with CD3 and is excluded from the immunologic synapse upon triggering with a polarizing stimulus. 
Cells were induced to express CD148 and stimulated with (A) PBS, (B) soluble anti-TCR (C305), (C) anti-TCR (C305)–coated coverslips, or (D) 
APCs with SAg (1 g/ml SEE). Immunofluorescence was performed using anti-hCD148 and anti-CD3 and the appropriate secondary anti-
bodies. CD148 is shown in red and CD3 is shown in green. For D, the lower panel for each stain represents the reconstructed Z stack contact 
view at the dotted line from the DIC image. (E) Jurkat cells were transfected with mCD148 and truncated hCD25, or (F) mCD148, mCD45RO, 
and truncated hCD25. Transfections were enriched for CD25 before conjugate formation. Cells were stained for mCD148 (red), CD3 
(green), and either (E) hCD43 (blue) or (F) mCD45 (blue). Bars, 5 m.
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As shown in Fig. 4 (E and F), both CD43 and CD45 colocal-
ized with CD148, demonstrating that CD148 is indeed ex-
cluded from the immunologic synapse.
 
The extracellular domain mediates 
exclusion from the synapse
 
To examine the mechanism that mediates the exclusion of
CD148 from the synapse, the entire extracellular domain of
CD148, with a FLAG epitope inserted just COOH terminal
to the signal peptide, was fused to the transmembrane do-
main of CD2 (FLAG–CD148–2TM). This chimeric mole-
cule was truncated after the sixth cytoplasmic amino acid to
prevent its association with CD2AP, as previous reports had
shown that CD2AP plays a role in receptor patterning and
cell polarization (Dustin et al., 1998). The localization of
FLAG–CD148–2TM protein was compared with a protein
that only has the FLAG epitope on the extracellular portion
of the molecule fused to the same CD2 transmembrane
domain (FLAG–CD2TM) (Fig. 5 A). The endogenous
CD148 signal sequence was used in both constructs for con-
sistency. Transfected Jurkat T cells were mixed with Daudi
B cells preincubated with SAg as before. Conjugates were vi-
sualized by immunofluorescence of the FLAG epitope (in
red) and CD3 (in green) (Fig. 5 B). The chimera containing
the full-length extracellular domain of CD148 was generally
excluded from the site of CD3 staining, whereas the mole-
cule containing only the FLAG epitope in the extracellular
domain showed considerable colocalization with CD3.
Quantitation of multiple conjugates fixed at a 25-min time
point determined that the FLAG–CD148–2TM chimera
was excluded a bit less frequently than wild-type CD148,
however much more frequently than just the FLAG–
CD2TM (Fig. 5 C). Conjugates were scored as “excluded” if
CD3 staining was tightly localized at the site of T cell–APC
contact and if the majority of FLAG staining did not colo-
calize with CD3. These data demonstrate that the extracellu-
lar domain does indeed play a major role in the exclusion of
CD148, but suggest that other factors may also be involved
in exclusion of CD148 from the immunologic synapse.
 
Targeting of the CD148 phosphatase domain to the 
synapse inhibits signaling
 
To determine if exclusion from the immunologic synapse
could limit the ability of CD148 to down-regulate NFAT, we
constructed a chimeric molecule that would target the
CD148 phosphatase domain into the synapse (Fig. 6 A). A
FLAG-tagged LAT extracellular and transmembrane region
was used because previous studies had demonstrated that
LAT colocalizes with CD3 (Harder and Kuhn, 2000; Bunnell
et al., 2002; Tanimura et al., 2003). Immunofluorescence
with antibodies to the FLAG epitope and the CD3
 

 
 chain of
TCR was performed to demonstrate that the chimera was in-
deed targeted to the immunologic synapse (Fig. 6 B). It is in-
teresting to note that the efficiency of mature synapse forma-
tion was decreased in cells expressing FLAG–LAT–CD148
compared with wild-type FLAG–CD148 (unpublished data).
To determine if targeting of the CD148 phosphatase do-
main to the synapse had a functional effect on T cell signal-
ing, an NFAT–luciferase reporter was cotransfected. Similar
to Fig. 1, the wild-type FLAG–CD148 construct inhibited
NFAT activation induced by soluble anti-TCR stimulation,
whereas plate-bound anti-TCR or SAg and APC stimulation
was only slightly affected. When the FLAG–LAT–CD148
chimera was expressed at the same level as the full-length
FLAG–CD148 molecule, as measured by FACS
 
®
 
 staining
for the FLAG epitope (unpublished data), it completely in-
hibited NFAT activation for all of the stimuli used. The
mean percent inhibition of NFAT activation is depicted in
Fig. 6 D. When transfected cells were also assayed for CD69
up-regulation in response to stimuli, the expression of
FLAG–LAT–CD148 dramatically inhibited CD69 up-regu-
lation in response to soluble anti-TCR and APCs with SEE
(Fig. 6 E). These experiments demonstrate that when the
phosphatase domain of CD148 is not excluded from the site
Figure 5. The extracellular domain of CD148 plays a role in exclusion from the immunologic synapse. (A) A representation of the chimeric 
molecule containing a FLAG epitope and the full-length mCD148 extracellular domain fused to a truncated hCD2 transmembrane domain 
(FLAG–CD148–2TM) was compared with an extracellular domain deletion chimera (FLAG–CD2TM). (B) Cells were transfected with one of 
the constructs along with truncated hCD25 and enriched for CD25 cells before conjugate formation. Conjugates were fixed and stained with 
anti-FLAG and anti-CD3, shown in red and green, respectively. The lower panel for each of stain represents the reconstructed Z stack contact 
view at the dotted line from the DIC image. Bars, 5 m. (C) Quantitation of the exclusion of each chimeric molecule out of the immunologic 
synapse was performed. The graph depicts the mean of two or three experiments, where between 30 and 60 conjugates for each construct 
were analyzed for each experiment. Error bars represent the standard error of the mean.
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of the immunologic synapse, it can potently inhibit TCR-
induced activation.
 
CD148 down-regulates prolonged T cell signaling
 
As expression of CD148 did not have an effect on SAg- and
APC-induced NFAT activation, presumably due to exclu-
sion from potential substrates associated with the TCR com-
plex, we wanted to test whether CD148 plays a role in
down-regulating prolonged T cell signaling events. Previous
studies had demonstrated that stimulation of primary hu-
man T cells with either phytohemagglutinin or anti-CD3
antibodies induces the up-regulation of CD148 after 48 h
Figure 6. Targeting of the CD148 phosphatase domain to the immunologic 
synapse inhibits NFAT activation. (A) A representation of the construct used 
for targeting the CD148 phosphatase domain to the synapse. FLAG–LAT–
CD148 was made by inserting a FLAG epitope in the extracellular domain of 
LAT and fusing the phosphatase domain of CD148 after the LAT transmembrane 
domain. (B) Transfected Jurkat T cells were enriched for transfected cells as 
before. Conjugates were formed, fixed, and stained with anti-FLAG and anti-
CD3, shown in red and green, respectively. Bars, 5 m. (C and D) Jurkat T 
cells were transfected with vector, 2 g of FLAG–CD148, or 2 g of FLAG–
LAT–CD148 along with 15 g of a 3xNFAT–luciferase reporter and rested 
overnight. Equal protein expression of the two constructs was assayed by flow 
cytometry for the FLAG epitope (not depicted). Cells were then stimulated 
with soluble anti-TCR (C305), plate-bound anti-TCR (C305), or APCs and SAg 
as in Fig. 1. (C) The means of triplicate samples in one representative experiment 
are shown. (D) The mean percent inhibition compared with vector control of 
each construct for each stimulus is shown where error bars represent standard 
error from three separate experiments, each done in triplicate. Relative light 
units were normalized to PMA/ionomycin. (E) Jurkat cells were transfected 
with vector or FLAG–LAT–CD148 and stimulated overnight with soluble 
anti-TCR, APCs and SEE, or PMA and ionomycin. Cells were then stained for 
CD69 and analyzed by flow cytometry gating only on transfected cells. The 
shaded histogram represents CD69 levels on unstimulated cells.
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(Tangye et al., 1998a). To more carefully study the time
course of CD148 up-regulation using a more physiologic
stimulus, we stimulated primary human CD4 T cells with a
mixture of SAgs (SEA, SED, and SEE) and assayed for
CD148 expression by FACS
 
®
 
 at 0, 4, 8, 16, 24, and 48 h af-
ter stimulation. As shown in Fig. 7 A, freshly isolated CD4
cells express low levels of CD148. However, after stimula-
tion, CD148 levels are increased, even at 4 h, and continue
to rise. CD148 expression was highest at 48 h.
As expression of CD148 continued to increase past 8 h,
we hypothesized that CD148 may play a role in down-regu-
lating the prolonged signaling events after the T cell has be-
come activated. To test this hypothesis, an NFAT reporter
construct was generated that expresses a destabilized form of
EGFP with a half-life of 2 h (4xNFAT–d2EGFP). This de-
stabilized form of GFP contains a PEST domain that has
been shown to target the protein for more rapid degradation
(Li et al., 1998). Response of the 4xNFAT–d2EGFP re-
porter could then be monitored at later time points by the
loss of GFP fluorescence. As earlier data showed that expres-
sion of CD148 in SAg- and APC-induced T cell activation
had no effect on activation up to 8 h and due to the nonsyn-
chronous nature of the inducible system, the reporter was
transfected into either CD148-expressing or nonexpressing
cells. When reporter-transfected Jurkat T cells inducibly ex-
pressing CD148 were stimulated with soluble anti-TCR,
NFAT activation was suppressed at all time points, similar
to that seen with the NFAT–luciferase construct at 8 h (Fig.
7 B). When these same cells were stimulated with SAg and
APCs, early NFAT responses were similar regardless of
CD148 expression, as seen before. However, at time points
after 8 h, cells expressing CD148 down-regulated NFAT ac-
tivation more rapidly than those not expressing CD148
(Fig. 7 C). These data indicate that CD148 does indeed play
a role in down-regulating the prolonged signaling events af-
ter SAg and APC stimulation.
Figure 7. Expression of CD148 inhibits 
prolonged NFAT signaling in T cell–APC 
conjugates. (A) Human PBMCs were 
isolated and stimulated with a cocktail 
of SEA, SED, and SEE (300 ng/ml each). 
Cells were stained at the indicated time 
points with anti-CD148 and anti-CD4. 
Histograms represent CD148 expression 
gated on CD4 cells. Shaded gray is 
the isotype control at each time point, 
whereas the t  0 (thin line) and the 
indicated time point (thick line) are 
overlaid. (B and C) Tet-inducible CD148 
Jurkats were induced for 48 h and then 
transfected with the 4xNFAT–d2EGFP 
reporter construct and truncated CD25 
as a transfection marker. Cells were rested 
for 6 h and then stimulated with the 
indicated stimulus. Cells were analyzed 
by FACS® at various time points by gating 
on CD25, 7-AAD cells (live cell 
marker) and reading out the geo mean 
fluorescence of the d2EGFP. (B) Cells 
with or without Dox were either mock 
stimulated or stimulated with soluble 
anti-TCR. (C) Cells with or without Dox 
were stimulated with either Raji B cells 
alone or Raji B cells with 250 ng/ml SEE. 
Shown is the mean from three separate 
experiments where error bars indicate 
the standard error.
Figure 8. Model of CD148 function in T cells. (A) A mature resting 
T cell in the periphery expresses low levels of CD148 at the cell 
surface. (B) When the T cell encounters an APC presenting the proper 
peptide or SAg, the T cell engages the APC and the TCR clusters at 
the site of APC contact. During this engagement, the T cell receives 
the proper signals for the up-regulation of CD148. (C) A fully mature 
synapse stabilizes the T cell–APC contact and prevents the up-
regulated CD148 molecules from dephosphorylating its substrates 
within the immunologic synapse. (D) Once the T cell has finished 
receiving all of the signals required for proliferation and IL-2 secretion, 
it releases the APC, allowing CD148 to redistribute, access its 
substrates, and down-regulate the sustained signaling events that are 
taking place at the synapse.
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Discussion
 
Based on this study, we propose the following model for the
role of CD148 in TCR signaling (Fig. 8). Resting T cells ex-
press low levels of CD148 at the cell surface. Upon engage-
ment of the TCR with the appropriate SAg or peptide-
loaded MHC molecule, signals are generated to up-regulate
the expression of CD148. The low amounts of CD148 that
are present at the cell surface are excluded as the immuno-
logic synapse forms. More importantly, the newly synthe-
sized CD148 that is made in response to the initial T cell ac-
tivation is excluded as well. This is critical, as we know that a
T cell must receive a continuous signal, on the order of
hours, to proliferate and generate IL-2. If CD148 were not
segregated away from potential substrates in the synapse,
premature termination of T cell response would occur.
Once the T cell has disengaged from the APC, CD148 can
access its substrates, leading to the dephosphorylation of
LAT, PLC-
 

 
1, and other substrates, thereby down-regulat-
ing prolonged T cell activation.
To date, the studies investigating the role of CD148 in
TCR signaling have relied solely upon soluble stimuli such as
phytohemagglutinin, PMA and ionomycin, or soluble anti-
TCR Ab (Tangye et al., 1998a,b; Baker et al., 2001). These
techniques, though effective in activating T cells, do not take
into consideration T cell polarization after receptor engage-
ment. To further investigate the function of CD148 in TCR
signaling, we used more physiologic, polarizing stimuli. In
experiments involving plate-bound anti-TCR mAb, bead-
coated anti-TCR mAb, and APCs presenting SAg, expres-
sion of CD148 had only a minimal effect on TCR signaling
events such as CD69 up-regulation and NFAT activation at
early time points. Previous studies have demonstrated that
these polarizing stimuli induce the formation of an immuno-
logic synapse-like structure enriched in the TCR and down-
stream signaling molecules (Lowin-Kropf et al., 1998;
Roumier et al., 2001; Bunnell et al., 2002). During T cell
engagement by an APC with SAg, CD148 was excluded
from the immunologic synapse, leading to the notion that
this serves to sequester CD148 from substrates that are local-
ized within the synapse, such as LAT. In contrast, when the
phosphatase domain of CD148 was targeted to the synapse,
NFAT activation was completely inhibited.
The data presented here support a model proposed by van
der Merwe et al. (2000), termed the kinetic-segregation
model of TCR triggering. This model suggests that the role
of the immunologic synapse is to create a “prosignaling” en-
vironment by the exclusion of active tyrosine phosphatases
and the enrichment of tyrosine kinases. In this model, the
initial interaction between the APC and TCR is regulated by
multiple small close-contact zones within the contact area
that result in the “small-scale” segregation of molecules (van
der Merwe et al., 2000). Areas such as these could explain
why the tyrosine phosphorylation induced with anti-TCR–
coated beads is not affected by CD148 even at very early
time points (1–3 min). These time points are well under the
amount of time it takes to form a mature immunologic syn-
apse (Bromley et al., 2001).
For the purposes of this study, the term immunologic syn-
apse is used to describe the area of TCR enrichment. The
immunologic synapse was originally described as being com-
posed of two parts: the central supramolecular activation
cluster (c-SMAC) and the peripheral SMAC (p-SMAC)
(Monks et al., 1998). The c-SMAC contains proteins such
as the TCR complex, CD28, PKC-
 
	
 
, and src family kinases.
The p-SMAC, consisting of proteins such as CD2, LFA-1,
and talin, appears as a ring that surrounds the c-SMAC.
Most studies of the immunologic synapse have been done
using mouse T cell clones that respond to APC loaded with
a specific peptide (Bromley et al., 2001; van der Merwe,
2002). As a reactive peptide for Jurkat T cells is not known,
the SAg system was used to mimic peptide-dependent inter-
actions between the TCR and MHC. In the case of Jurkats
stimulated with SAg, we were never able to clearly discrimi-
nate between c-SMAC and p-SMAC structures as described
in mouse clones and preactivated T cells. In general, the site
of APC contact in this system showed colocalization of mol-
ecules from both the c-SMAC and p-SMAC (unpublished
data). This may be a characteristic of Jurkat cells interacting
with SAg and APCs, or it may be a feature of T cells stimu-
lated with SAg. It is important to note that proteins such as
CD43 and CD45, excluded from the synapse in mouse
clones, were also excluded in the Jurkat–SAg system.
With the elucidation of the ezrin/radixin/moesin (ERM)-
mediated mechanism for CD43 exclusion from the immu-
nologic synapse, the model of purely size-based exclusion
has become less favored. However, many groups have dem-
onstrated that altering the size of extracellular domains can
alter the function of proteins such as CD45 and CD48
(Wild et al., 1999; Irles et al., 2003). The attachment of the
CD148 extracellular domain onto the TM of CD2 alone
was enough to cause the exclusion of the chimera from the
immunologic synapse, albeit not to the same extent as native
CD148. When cells expressing the FLAG–CD148–2TM
construct were dropped onto anti-TCR–coated coverslips,
the chimera was not excluded (unpublished data). One pos-
sible interpretation is that dropping cells onto a coverslip
does not confer the same spatial constraints that are involved
in T cell–APC conjugates. Another is that a possible ligand
on the APC may be involved in the exclusion from the syn-
apse. These data suggest that the extracellular domain plays
an important role, but other factors requiring the cytoplas-
mic domain also contribute to the exclusion of CD148 from
the synapse. As CD148 has a very similar distribution on the
cell surface to that of CD43, an obvious candidate for one of
these other factors involved in the exclusion of CD148 was
that of the ERM family. Previous studies have mapped the
ERM protein’s association with CD43, CD44, and ICAM-2
to a series of positively charged amino acids in the jux-
tamembrane cytoplasmic domain (Yonemura et al., 1998).
CD148 does have a similar stretch of residues, but almost all
transmembrane proteins do, presumably as a stop-transfer
sequence for the transmembrane domain. Experiments at-
tempting to coimmunoprecipitate ezrin with CD148 did
not reveal any association of the two proteins (unpublished
data). Moreover, the FLAG–LAT–CD148 chimera still con-
tains this string of charged residues on the cytoplasmic face
of the TM domain. This construct localized to the synapse,
implying that the charged residues do not play a critical role
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in the exclusion of CD148. Another possible mechanism
mediating the exclusion of CD148 from the synapse is the
PDZ binding motif present at the very COOH terminus of
CD148, which has been demonstrated to bind syntenin
(Iuliano et al., 2001). When the GYIA motif was deleted,
this truncated CD148 functioned similarly to wild-type
CD148 in its ability to down-regulate NFAT in response to
stimulation with soluble anti-TCR mAb. The PDZ mutant
also did not inhibit the immobilized anti-TCR or SAg and
APC stimulation, nor was it localized differentially by im-
munofluorescence microscopy compared with wild-type
CD148 (unpublished data).
The role of the immunologic synapse in T cell–APC inter-
actions has remained a controversial topic. From studies ex-
amining tyrosine phosphorylation by biochemistry and syn-
apse formation by microscopy, it is clear that signaling
precedes the formation of the synapse (Lee et al., 2002). Ob-
servations such as these have led us to propose that the synapse
is a mechanism whereby the cell can prevent the premature
termination of a productive signaling event, as inhibitory pro-
teins such as CD148 become up-regulated. Once the T cell
has obtained the signal it requires for proliferation and other
effector functions, it disengages from the APC, which then al-
lows CD148 to redistribute and gain access to and dephos-
phorylate substrates. This segregation of phosphatases from
their substrates is potentially yet another layer of regulation,
beyond protein expression, enzymatic activation, or protein–
protein interactions, for the control of T cell activation.
 
Materials and methods
 
Antibodies and cells 
 
TCR stimulation was performed with the anti–Jurkat TCR V
 

 
8 monoclonal
antibody (mAb) C305 (Weiss and Stobo, 1984). The antiphosphotyrosine
(4G10) and anti-FLAG (M2) mAbs are from Upstate Biotechnology and
Sigma-Aldrich, respectively. 7-AAD, anti-CD5 (L17F12), anti-CD25 (2A3),
anti-CD69 (L78), anti-CD3
 

 
 (SK7), and anti-mCD45 (30F-11) are from BD
Biosciences. Anti–human CD148 (A3) has been previously described
(Tangye et al., 1998a). Anti–mouse CD148 (8A-1) was generated by immu-
nizing a hamster with cells expressing murine CD148 and screening hy-
bridomas for antibodies specific to the extracellular domain of murine
CD148. Anti–human CD43 was a gift from L. Lanier (University of Califor-
nia, San Francisco). Streptavidin conjugated to Alexa 488, 555, and 647
were from Molecular Probes, and goat anti–mouse IgG-Cy5 and donkey
anti–rat IgG-Cy3 were from Jackson ImmunoResearch Laboratories. Jurkat
T cells, Daudi B cells, and Raji B cells were maintained in RPMI 1640 sup-
plemented with 10% FBS, 2 mM glutamine, penicillin, and streptomycin.
Tetracycline-inducible CD148 cells (clone L12) were previously described
(Baker et al., 2001). For PBMC (peripheral blood mononuclear cell) sepa-
ration, buffy coats from whole blood were layered onto Ficoll-Hypaque
(Sigma-Aldrich) and centrifuged at 350 
 
g
 
 for 30 min at RT. Cells were
washed and resuspended in RPMI 1640 with 10% FBS, 2 mM glutamine,
penicillin, and streptomycin.
 
Plasmids
 
pcdef3-mCD148 was constructed by removing the mCD148 cDNA from
pME18S-Byp (a gift from H. Umemori (University of Tokyo, Tokyo, Japan)
and inserting it into pcdef3 vector cut with EcoRV. This version of the
mCD148 cDNA has a T175S, compared with the published sequence.
FLAG–mCD148 was generated by inserting a FLAG epitope between
Ala38 and Ala39 (after the signal sequence) in pcdef3-mCD148. Residue
numbers for FLAG–mCD148 do not include the amino acids from the
FLAG epitope. FLAG–CD148–2TM was created by fusing the FLAG–
mCD148 extracellular domain at Asp870 to Ile210 of hCD2. The FLAG–
CD2TM construct was made by fusing the signal sequence and FLAG
epitope of FLAG–mCD148 at Ala48 to Gly207 of hCD2. Both CD2-con-
taining constructs were truncated at Arg241. The FLAG–LAT–CD148 con-
struct was made by first inserting a FLAG epitope after the start methionine
of human LAT. The fusion joined LAT (Pro33) to mCD148 (Phe896) with a
Ser linking the two fragments. Fusion constructs were made by multistep
PCR, and all final products were sequenced. The 3xNFAT–luciferase plas-
mid was previously described (Shapiro et al., 1996). Murine CD45RO was
expressed in a pcdef3 expression construct. The 4xNFAT–d2EGFP was
made by replacing the EGFP from a 4xNFAT–EGFP with the d2EGFP
(CLONTECH Laboratories, Inc.). The original 4xNFAT–EGFP was made by
placing four copies of the NFAT/AP-1 binding site from IL-2 promoter in
pEGFP-1 (CLONTECH Laboratories, Inc.).
 
APC and SAg stimulation
 
Equal numbers of Daudi or Raji B cells were used as APCs. Cells were
loaded with the indicated staphylococcal enterotoxin (SE) SAg for 30 min
before stimulation. SEE, SEA, and SED were purchased from Toxin Technol-
ogy, Inc. For PBMC stimulation, a mixture of SEA, SED, and SEE were used
at 300 ng/ml of each type. Cells were centrifuged to the bottom of a round
bottom tube to initiate stimulation and left undisturbed until time of harvest.
 
Transfection and enrichment
 
Jurkat cells were transfected as previously described (Baker et al., 2001).
For enrichment of transfected cells, cells were cotransfected with a trun-
cated CD25 construct. 18 h later, cells were labeled with anti–human
CD25 MACS beads (Miltenyi Biotec) for 20 min on ice and then washed.
Cells were positively selected with an LS column and MACS magnet
(Miltenyi Biotec). Enriched cells were resuspended in media and allowed
to rest for 2 h.
 
Lysates and Western blots
 
Cells were lysed in 1% NP-40 and visualized by Western blotting as previ-
ously described (Lin and Weiss, 2001a). For quantitation of Western blots,
bands were quantitated on a Kodak Imaging Station using Kodak 1D image
analysis software version 3.5 (Eastman Kodak Co.).
 
Immunofluorescence
 
Cells were placed onto poly-
 
L
 
-lysine–coated slides and allowed to settle
for 5 min. Conjugates were made by preloading Daudi B cells with 1 
 

 
g/
ml of SEE for 30 min before mixing 1:1 with T cells in complete media.
Cells were then gently centrifuged for 30 s and placed at 37
 


 
C for 25 min.
Conjugates were gently resuspended and allowed to settle on slides as be-
fore. Paraformaldehyde was added to 3% final concentration for 30 min.
Cells were then blocked in 1% BSA and 10% rabbit serum in PBS. Cells
were stained with the indicated antibodies, followed by the appropriate
secondary antibodies when necessary. Slides were visualized on a Mari-
anas Turn-Key system from Intelligent Imaging, and images were analyzed
using SlideBook software. Images were deconvolved by nearest neighbor
and exported as TIFF files.
 
Reporter assays
 
Jurkat cells were transfected as before with 20 
 

 
g of a 3xNFAT–luciferase
reporter construct and the indicated CD148 construct. Expression of the
CD148 constructs was examined by FACS
 
®
 
. Stimulation for luciferase as-
says was performed for 8 h. Cells were harvested, lysed, and assayed for
luciferase activity as previously described (Shapiro et al., 1996). For NFAT
activation time course experiments, CD148 was induced on clone L12 for
48 h before transfection. 15 
 

 
g of a truncated CD25 construct was cotrans-
fected with 20 
 

 
g of the 4xNFAT–d2EGFP reporter. The cells were allowed
to recover for 6 h before stimulation. NFAT activation was assessed as the
geometric mean fluorescence intensity of CD25
 

 
, 7-AAD
 

 
 cells.
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